Approval · Notice of Compliance 438 · 2002
HYPAQUE-M 76%: Notice of Compliance 438
Issued June 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 438
- Date
- June 20, 2002
- Company
- Amersham Health Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Radiopaque contrast media
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYPAQUE-M 76% | 02180677 | Cancelled Post Market |
Medicinal ingredients
- DIATRIZOATE SODIUM 10 PER
- DIATRIZOATE MEGLUMINE 66 PER